Literature DB >> 34228130

Inclusion of Underrepresented Groups in Preclinical Alzheimer Disease Trials-Opportunities Abound.

Jennifer J Manly1, Andrea Gilmore-Bykovskyi2, Kacie D Deters3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34228130     DOI： 10.1001/jamanetworkopen.2021.14606

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  3 in total

Review 1.  A cultural approach to dementia - insights from US Latino and other minoritized groups.

Authors:  Clara Vila-Castelar; Joshua T Fox-Fuller; Edmarie Guzmán-Vélez; Dorothee Schoemaker; Yakeel T Quiroz
Journal:  Nat Rev Neurol       Date:  2022-03-08       Impact factor: 44.711

2.  Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.

Authors:  Jack C Lennon; Stephen L Aita; Victor A Del Bene; Tasha Rhoads; Zachary J Resch; Janelle M Eloi; Keenan A Walker
Journal:  Alzheimers Dement       Date:  2021-12-02       Impact factor: 16.655

3.  You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.

Authors:  Emily A Largent; Twisha Bhardwaj; Justin T Clapp; Olivia Saúl Sykes; Kristin Harkins; Joshua D Grill
Journal:  J Alzheimers Dis       Date:  2022-03-18       Impact factor: 4.160
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.